Medpace Holdings Inc

XETRA • Healthcare • Diagnostics & Research • Quote as of 10/27/2026 17:35

Company Profile

IndustryDiagnostics & Research

SectorHealthcare

ExchangeXETRA

Market Capitalization15,472 mln

Earnings Date10/19/2026

EPS

14.62

Stretched

P / E

41.50

High premium

Piotroski F-Score

8 / 9

Very strong

Beneish M-Score

-2.89

Likely reliable

Relative Strength

97 / 100

Top performer

Debt / Equity

0.33

Low leverage

Key Fundamentals

EPS14.62

P/E41.50

ROE126

ROIC24.12

ROA25.90

EBITDA, mln537

EV / EBITDA27.75

EV / EBIT29.04

Revenue, mln2,386

EV / Revenue6.25

Quote Details

Last 605.80

Change 3.6 (0.6%)

Open 602.40

Volume 51

Turnover 30,896

Average Volume 22.1

Financial Ratios

Pre-Tax Profit Margin22

Current Ratio0.73

Price / Book39.94

Price / Free Cash Flow25.40

Debt / Equity0.33

Price / Sales6.45

PEG Ratio1.20

Financial Strength

Altman Z-Score8.16

Piotroski F-Score 8 / 9

Beneish M-Score-2.89

Price to Intrinsic Value2.62

Price to Lynch Fair Value1.46

Shiller PE Ratio83.81

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	7.68%	97 / 100
1 Month	12.02%	94 / 100